Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP418870.RAWoCdbKtP1pp0jlWiKq-qZf8inSBLg_XOR_4TF8V11mo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP418870.RAWoCdbKtP1pp0jlWiKq-qZf8inSBLg_XOR_4TF8V11mo130_assertion type Assertion NP418870.RAWoCdbKtP1pp0jlWiKq-qZf8inSBLg_XOR_4TF8V11mo130_head.
- NP418870.RAWoCdbKtP1pp0jlWiKq-qZf8inSBLg_XOR_4TF8V11mo130_assertion description "[Constitutively activating mutations of FMS-like tyrosine kinase 3 (FLT3) occur in approximately one third of patients with acute myeloid leukemia (AML) and are associated with poor prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418870.RAWoCdbKtP1pp0jlWiKq-qZf8inSBLg_XOR_4TF8V11mo130_provenance.
- NP418870.RAWoCdbKtP1pp0jlWiKq-qZf8inSBLg_XOR_4TF8V11mo130_assertion evidence source_evidence_literature NP418870.RAWoCdbKtP1pp0jlWiKq-qZf8inSBLg_XOR_4TF8V11mo130_provenance.
- NP418870.RAWoCdbKtP1pp0jlWiKq-qZf8inSBLg_XOR_4TF8V11mo130_assertion SIO_000772 14592841 NP418870.RAWoCdbKtP1pp0jlWiKq-qZf8inSBLg_XOR_4TF8V11mo130_provenance.
- NP418870.RAWoCdbKtP1pp0jlWiKq-qZf8inSBLg_XOR_4TF8V11mo130_assertion wasDerivedFrom befree-2016 NP418870.RAWoCdbKtP1pp0jlWiKq-qZf8inSBLg_XOR_4TF8V11mo130_provenance.
- NP418870.RAWoCdbKtP1pp0jlWiKq-qZf8inSBLg_XOR_4TF8V11mo130_assertion wasGeneratedBy ECO_0000203 NP418870.RAWoCdbKtP1pp0jlWiKq-qZf8inSBLg_XOR_4TF8V11mo130_provenance.